Kunwha Pharmaceutical, The stock price drops to the lowest limit due to recapitalization to raise funds to take over Dream Pharma

Published: 2014-10-29 15:39:16

Updated: 2014-10-29 15:39:16

Kunwha Pharmaceutical posted a notice of KRW 134.345 billion worth of recapitalization to raise funds to take over 100% shares of the drug manufacturing corporation divided from Dream Pharma.

The number of the newly issued shares is 9.7 million shares, and the number of new stock allotment per a share is 1.9836457 shares.

The issue price for a new share is KRW 13.85 thousand; the offering for...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.